Expansion of Lung Vα14 NKT Cells by Administration of α-Galactosylceramide-pulsed Dendritic Cells-Reference-Cited by-同舟云学术

Expansion of Lung Vα14 NKT Cells by Administration of α-Galactosylceramide-pulsed Dendritic Cells

Published:2002-04 Issue:4 Volume:93 Page:397-403
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Akutsu Yasunori,Nakayama Toshinori,Harada Michishige,Kawano Tetsu,Motohashi Shinichiro,Shimizu Eiko,Ito Toshihiro,Kamada Noriaki,Saito Takeshi,Matsubara Hisahiro,Miyazawa Yukimasa,Ochiai Takenori,Taniguchi Masaru

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2002.tb01270.x/fullpdf

Reference37 articles.

1. Recognition and function of Vα14 NKT cells;Taniguchi;Semin. Immunol.,2000

2. Homogenous junctional sequence of the Vα14+ T-cell antigen receptor a chain expanded in unprimed mice;Koseki;Proc. Natl. Acad. Sci. USA,1990

3. An invariant T cell receptor α chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans;Lantz;J. Exp. Med.,1994

4. Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations;Makino;Int. Immunol.,1995

5. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes;Sharif;Nat. Med.,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial;Trials;2017-09-15

2. Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy;Anti-Cancer Agents in Medicinal Chemistry;2014-01-31

3. Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model;PLoS ONE;2013-05-31

4. NKT Cells as an Ideal Anti-Tumor Immunotherapeutic;Frontiers in Immunology;2013

5. Clinical Trials of Invariant Natural Killer T Cell-Based Immunotherapy for Cancer;Natural Killer T cells;2011-08-14